Correlation Between Moderna and Onxeo SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Moderna and Onxeo SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moderna and Onxeo SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moderna and Onxeo SA, you can compare the effects of market volatilities on Moderna and Onxeo SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moderna with a short position of Onxeo SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moderna and Onxeo SA.

Diversification Opportunities for Moderna and Onxeo SA

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between Moderna and Onxeo is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Moderna and Onxeo SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Onxeo SA and Moderna is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moderna are associated (or correlated) with Onxeo SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Onxeo SA has no effect on the direction of Moderna i.e., Moderna and Onxeo SA go up and down completely randomly.

Pair Corralation between Moderna and Onxeo SA

Assuming the 90 days horizon Moderna is expected to under-perform the Onxeo SA. But the stock apears to be less risky and, when comparing its historical volatility, Moderna is 2.34 times less risky than Onxeo SA. The stock trades about -0.07 of its potential returns per unit of risk. The Onxeo SA is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  15.00  in Onxeo SA on September 5, 2024 and sell it today you would lose (7.77) from holding Onxeo SA or give up 51.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Moderna  vs.  Onxeo SA

 Performance 
       Timeline  
Moderna 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Moderna has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Onxeo SA 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Onxeo SA are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Onxeo SA reported solid returns over the last few months and may actually be approaching a breakup point.

Moderna and Onxeo SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Moderna and Onxeo SA

The main advantage of trading using opposite Moderna and Onxeo SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moderna position performs unexpectedly, Onxeo SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Onxeo SA will offset losses from the drop in Onxeo SA's long position.
The idea behind Moderna and Onxeo SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities